Article
Double-hit lymphomas: current paradigms and novel treatment approaches.
Hematology. American Society of Hematology. Education Program - 5 Dec 2014
Dunleavy Kieron
Abstract excerpt
Double-hit lymphomas (DHLs) are a heterogeneous group of mature B-cell lymphomas that harbor concurrent rearrangements of MYC and BCL2 or, occasionally, BCL6. Several studies have now shown that they are associated with a very aggressive clinical course and poor outcome after standard R-CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) therapy, with few patients surviving beyond 2 years. Due to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
